FisherVista

This article explores strategies for obtaining affordable dental implants, emphasizing the importance of comparing clinics, understanding pricing, and choosing experienced professionals to ensure long-term value.

A business delegation led by Hong Kong’s Chief Executive signed 43 memoranda of understanding with Kazakh partners, covering trade, finance, technology, and aviation, underscoring Hong Kong’s role as a two-way services platform under the Belt and Road Initiative.

Yocale.ai appoints former Electronic Arts CTO Marija Radulovic-Nastic to its advisory board, signaling a strategic push to embed AI deeply into its platform for the beauty and wellness industry.

Shelly Group appoints Georgi Bonev as Chief Marketing Officer to lead global marketing strategy and support international scaling, leveraging his experience from Samsung, Lenovo, and TP Vision.

Viromed Medical AG completed a multi-year study confirming cold atmospheric plasma's potential to treat ventilator-associated pneumonia, with first successful patient applications in a university hospital setting.

At TeamViewer's 2026 Annual General Meeting, shareholders elected Andrea Euenheim to the Supervisory Board and approved all agenda items with a large majority, reflecting confidence in the company's strategic direction.

PSI Software SE delays release of audited 2025 financial statements until June 2026 due to pending approval of Warburg Pincus tender offer under investment control regulations.

Quantum BioPharma's lead drug candidate Lucid-MS targets nerve damage in multiple sclerosis, with a Phase 2 trial upcoming, while its commercial product unbuzzd™ generates royalty revenue.

Perpetuals.com Ltd. announced over 30,000 active users and $4.5 billion in trading volume in its first two weeks for its UpsideOnly platform, and signed an agreement with Datavault AI to tokenize real-world commodity assets.

BOXABL, merging with FG Merger II (NASDAQ: FGMC), uses centralized manufacturing to address housing affordability, with a $3.5 billion valuation and capacity to produce up to 5,000 units annually.

The AI-driven surge in semiconductor stocks, led by TSMC and memory-chip makers, prompts analysts to question whether the rally reflects a structural shift or a speculative bubble.

Advances in artificial intelligence and edge computing are turning health care wearables into powerful clinical tools that can deliver real-time, actionable insights, benefiting companies like Apple and improving remote patient monitoring and access to care.

Datavault AI (NASDAQ: DVLT) announced a non-binding term sheet for a potential $2 billion dilutive structured financing aimed at funding its digital asset exchanges and real-world asset tokenization initiatives.

Regentis Biomaterials is progressing its cell-free hydrogel implant GelrinC through a pivotal U.S. Phase III trial, aiming to address a $3 billion market with no approved off-the-shelf regenerative solution.

A new American Heart Association scientific statement projects that 6 in 10 U.S. women will have cardiovascular disease by 2050, driven by increases in obesity and diabetes, but emphasizes prevention through lifestyle changes.

Datavault AI has partnered with Perpetuals.com to list RWA token programs on a regulated exchange, starting with the MTB Copper project, aiming to democratize access to tokenized physical commodities.

A new survey from Consolidated Credit reveals that nearly 30% of Americans carrying credit card debt owe $10,000 or more, yet many delay seeking professional help until debt becomes overwhelming, highlighting a need for greater consumer education.

The Calderón Law Firm commemorated its first anniversary and the inauguration of new strategic offices in South Florida, highlighting its role in cross-border corporate legal services and asset protection.

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC platform as a potential first-in-class, off-the-shelf solution for knee cartilage repair, targeting a $3 billion U.S. market with clinical data showing approximately 100% greater pain improvement versus microfracture.